Tumor suppressor gene allelic loss profiles of the variants of papillary thyroid carcinoma.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 15163008)

Published in Diagn Mol Pathol on March 01, 2004

Authors

Jennifer L Hunt1, Melissa Fowler, Deren Lomago, Laura Niehouse, Eizaburo Sasatomi, Patricia Swalsky, Sydney Finkelstein

Author Affiliations

1: Department of Pathology, University of Pittsburgh Medical Center, Presbyterian Hospital, Pittsburgh, PA 15213, USA. HUNTJL@msx.upmc.edu

Articles by these authors

Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol (2004) 6.99

Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res (2002) 2.52

Gene expression analysis of prostate cancers. Mol Carcinog (2002) 2.51

The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology. Clin Gastroenterol Hepatol (2005) 1.78

Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol (2004) 1.46

Molecular analysis to demonstrate that odontogenic keratocysts are neoplastic. Arch Pathol Lab Med (2004) 1.45

Why good leaders make bad decisions. Harv Bus Rev (2009) 1.40

Low overexpression of HER-2/neu in advanced colorectal cancer limits the usefulness of trastuzumab (Herceptin) and irinotecan as therapy. A phase II trial. Cancer Invest (2004) 1.33

Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy. Transplantation (2002) 1.23

Multifaceted resistance of gliomas to temozolomide. Clin Cancer Res (2002) 1.22

The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma. Neoplasia (2005) 1.12

Molecular pathogenesis of pulmonary carcinosarcoma as determined by microdissection-based allelotyping. Am J Surg Pathol (2002) 1.11

Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis. Liver Transpl (2009) 1.10

Patterns of allelic loss of synchronous adenocarcinomas of the lung. Am J Surg Pathol (2005) 1.08

Caveat emptor: submitting the entire gallbladder in cases of dysplasia is not justified. Am J Clin Pathol (2013) 1.08

Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival. Liver Transpl (2003) 1.08

Inflammatory fibroid polyps of the gastrointestinal tract: clinical, pathologic, and molecular characteristics. Appl Immunohistochem Mol Morphol (2004) 1.06

Allelic loss of tumor suppressor genes in ameloblastic tumors. Mod Pathol (2004) 1.05

Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma. Hepatology (2003) 1.03

Molecular evidence for the neoplastic potential of hepatic Von-Meyenburg complexes. Appl Immunohistochem Mol Morphol (2010) 1.00

Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas. Neurosurgery (2004) 0.99

DNA sequencing of viral capsid protein VP-1 region in patients with BK virus interstitial nephritis. Transplantation (2002) 0.99

A microdissection and molecular genotyping assay to confirm the identity of tissue floaters in paraffin-embedded tissue blocks. Arch Pathol Lab Med (2003) 0.98

High throughput screening of methylation status of genes in prostate cancer using an oligonucleotide methylation array. Carcinogenesis (2004) 0.96

Viral regulatory region sequence variations in kidney tissue obtained from patients with BK virus nephropathy. Kidney Int (2003) 0.95

Molecular genotyping of medullary thyroid carcinoma can predict tumor recurrence. Am J Surg Pathol (2004) 0.94

Liver-specific β-catenin knockout mice have bile canalicular abnormalities, bile secretory defect, and intrahepatic cholestasis. Hepatology (2010) 0.93

Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid. Am J Surg Pathol (2003) 0.90

Heterotopic breast epithelial inclusion of the heart: report of a case. Am J Surg Pathol (2010) 0.88

Effects of ethyl pyruvate and other α-keto carboxylic acid derivatives in a rat model of multivisceral ischemia and reperfusion. J Surg Res (2009) 0.88

Loss of heterozygosity patterns of sclerosing hemangioma of the lung and bronchioloalveolar carcinoma indicate a similar molecular pathogenesis. Arch Pathol Lab Med (2004) 0.87

Molecular analysis of primary and recurrent giant cell tumors of bone. Cancer Genet Cytogenet (2005) 0.85

Microdissection-based mutational genotyping of serous borderline tumors of the ovary. Int J Gynecol Pathol (2005) 0.85

Endoscopic ultrasound-guided fine needle aspirate microsatellite loss analysis and pancreatic endocrine tumor outcome. Clin Gastroenterol Hepatol (2006) 0.85

Segmental colitis associated with diverticulosis. Dig Dis Sci (2002) 0.84

Loss of heterozygosity mutations of tumor suppressor genes in cytologically atypical areas in chronic lymphocytic thyroiditis. Endocr Pathol (2002) 0.84

Loss of heterozygosity reveals non-VHL allelic loss in hemangioblastomas at 22q13. Hum Pathol (2004) 0.82

Pulmonary meningothelial-like nodules: a genotypic comparison with meningiomas. Am J Surg Pathol (2004) 0.82

Infiltrative hepatocellular carcinoma: what radiologists need to know. Radiographics (2015) 0.81

Correlation of the presence and extent of loss of heterozygosity mutations with histological classifications of Barrett's esophagus. BMC Gastroenterol (2012) 0.81

Immunohistochemical markers of tissue injury in biopsies with transplant glomerulitis. Hum Pathol (2011) 0.80

Molecular diagnosis of solid and cystic lesions of the pancreas. Gastroenterol Clin North Am (2004) 0.79

Assessment of mutational load in biopsy tissue provides additional information about genomic instability to histological classifications of Barrett's esophagus. J Gastrointest Cancer (2014) 0.79

Risk assignment in childhood brain tumors: the emerging role of molecular and biologic classification. Curr Oncol Rep (2002) 0.79

Pathologic features of early inflammatory bowel disease. Gastroenterol Clin North Am (2002) 0.79

Celecoxib-induced cholestatic liver failure requiring orthotopic liver transplantation. World J Gastroenterol (2009) 0.79

Loss of heterozygosity of the VHL gene identifies malignancy and predicts death in follicular thyroid tumors. Surgery (2003) 0.79

DNA mutational differences in cytological specimens from pancreatic cancer and cholangiocarcinoma. Pancreatology (2010) 0.79

A novel microdissection and genotyping of follicular-derived thyroid tumors to predict aggressiveness. Hum Pathol (2003) 0.79

Analysis of loss of heterozygosity in atypical and negative bile duct brushing cytology specimens with malignant outcome: are "false-negative" cytologic findings a representation of morphologically subtle molecular alterations? Arch Pathol Lab Med (2007) 0.78

Microscopic papillary thyroid carcinoma compared with clinical carcinomas by loss of heterozygosity mutational profile. Am J Surg Pathol (2003) 0.78

Synchronous unilateral renal cell carcinoma and Kimura disease of the kidney. Urology (2006) 0.78

Overexpression of the human inducible nitric oxide synthase gene enhances radiation-induced apoptosis in colorectal cancer cells via a caspase-dependent mechanism. Nitric Oxide (2003) 0.77

Microsatellite instability is uncommon in lymphoepithelioma-like carcinoma of the lung. Am J Clin Pathol (2007) 0.77

Microdissection-based genotyping assists discrimination of reactive gliosis from glioma. Am J Clin Pathol (2004) 0.76

Widespread molecular alterations present in stage I non-small cell lung carcinoma fail to predict tumor recurrence. Mod Pathol (2003) 0.76

Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: a pilot study. J Thorac Cardiovasc Surg (2004) 0.76

Microdissection genotyping of gliomas: therapeutic and prognostic considerations. Mod Pathol (2004) 0.76

Primary duodenal carcinoma showing divergent growth patterns as determined by microdissection-based mutational genotyping. Arch Pathol Lab Med (2003) 0.76

Comparative mutational analysis of pulmonary scar epithelium, bronchioloalveolar carcinomas, and invasive well-differentiated pulmonary adenocarcinomas: a molecular approach to diagnostically challenging cases. Am J Surg Pathol (2005) 0.75

Microdissection genotyping of archival fixative treated tissue for Gaucher disease. Hum Pathol (2004) 0.75

Molecular diagnosis of solid and cystic lesions of the pancreas. Clin Lab Med (2005) 0.75